Stroke mortality rates have been declining in almost every country. Reduction in mortality could result from a decline in disease occurrence or a decline in case fatality, or both. A reduction in [...]

  With over 2 million new cases annually, stroke is associated with the highest disability-adjusted life-years lost of any disease in China. The burden is expected to increase further as a [...]

Intensive intravenous glucose control did not improve functional outcome compared with standard insulin control in patients with stroke who have hyperglycaemia— and it may even increase the risk [...]

Intensive blood pressure lowering in patients treated with alteplase for acute ischaemic stroke did not lead to a significant improvement in outcome compared with guideline based blood pressure [...]

Systolic blood pressure of more than 185 mm Hg is a contraindication to thrombolytic treatment with intravenous alteplase in patients with acute ischaemic stroke, but the target systolic blood [...]

Yongjun Wang and colleagues discuss recent evidence for using dual antiplatelet therapy to reduce recurrence of stroke or transient ischaemic attack In summary, DAPT should be started as soon as [...]